News
-
Thalassemics India News Update
The latest news from TIF’s Member ”Thalassemics India” in one place! In this issue you will find all the information on the new Thalassaemia Screening & Counselling Center in New…
Read More » -
AstraZeneca Starts U.S. Final-Stage Trial of Covid-19 Vaccine
AstraZeneca Plc has begun final-stage, Phase III trial of its coronavirus vaccine AZD1222 in the U.S., according to the company´s latest statement. Trial centers across the US are recruiting up to 30,000 adults aged 18 years…
Read More » -
IMPORTANT ANNOUNCEMENT: TIF’s Renzo Galanello Fellowship Programme 2020 To Be Rescheduled and Compressed
Due to some difficulties and restrictions encountered as a result of the COVID-19 pandemic, the Renzo Galanello Fellowship Programme 2020 will not be offered in its full length and as initially…
Read More » -
TIF Has Joined the EASL Patient Organisations Community
TIF is constantly fortifying synergies with influential patient organisations for the benefit of individuals with thalassaemia and other Haemoglobin Disorders. Therefore, we are excited to announce that the Federation has recently joined one…
Read More » -
Pfizer Has Reached Over 50% Enrollment for Coronavirus Vaccine Candidate Phase 3 Trial
One of the leading COVID-19 vaccine candidates currently in development is getting closer to a potential finish line. Pfizer said on Wednesday that the recruitment for the crucial U.S. phase 3 clinical…
Read More » -
Malaysian Health Minister: The Country Needs More Geneticists to Detect Thalassaemia Early
Malaysia needs more geneticists in order to identify thalassaemia patients at an early stage, stated Health Minister Datuk Seri Dr Adham Baba, after launching the 2019 Malaysia Thalassaemia Registry (MTR)…
Read More » -
The eThalED Course Webinar Series Return With a New Session on Iron Monitoring in Thalassaemia
TIF´s upcoming webinar on ”Iron Monitoring in Thalassaemia”, specially designed and launched for medical specialists and healthcare professionals with a particular interest in the field of haemoglobin disorders and thalassaemia,…
Read More » -
-
Coronavirus Pandemic: How Close Are We to a Vaccine?
Researchers around the world are racing to develop a vaccine against Covid-19, with more than 140 candidate vaccines now tracked by the World Health Organization (WHO). Vaccines normally require years of testing…
Read More » -
”Blood Transfusion in Thalassaemia”: Save the Date for the Next TIF Webinar for Medical Specialists
TIF´s brand new Webinar, entitled ”Blood Transfusion in Thalassaemia” and organised as part of the eThalED Course, will be held on Monday, 31 August 2020, 15:00-16:00 EEST / 13:00-14:00 BST.…
Read More »